prostacyclins, analogues or prostaglandins and thromboxanantagonister for treatment of thrombotic and thromboembolic syndromes

摘要

Combination products containing a prostaglandine (PG), a prostacycline (PC) or a prostacycline analogue (PCA) and a thromboxane receptor antagonist (TXAA), suited for joint use in the treatment of forms of thrombotic or thrombo-embolic illnesses.